Sort   by:  
 Page size 
UnknownComparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma project.
Not available
S-EPMC12819374 | biostudies-literature
UnknownOligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors.
Not available
S-EPMC7226015 | biostudies-literature
UnknownMultimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach.
Not available
S-EPMC9742626 | biostudies-literature
UnknownReal-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
Not available
S-EPMC8366107 | biostudies-literature
UnknownDetection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival.
Not available
S-EPMC6356563 | biostudies-literature
UnknownComprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives.
Not available
S-EPMC7481602 | biostudies-literature
UnknownLeveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.
Not available
S-EPMC5509161 | biostudies-literature
UnknownAssociation of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC8417333 | biostudies-literature
UnknownHealth-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension.
Not available
S-EPMC11762039 | biostudies-literature
UnknownLongitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset.
Not available
S-EPMC10647003 | biostudies-literature
Sort   by:  
 Page size